Literature DB >> 10816008

Molecular modeling of the catalytic domain of serine/threonine phosphatase-1 with the Zn2+ and Mn2+ di-nuclear ion centers in the active site.

E Wozniak1, S Ołdziej, J Ciarkowski.   

Abstract

Catalytic domains of the metalloenzymes protein phosphatases (PPP) 1, 2A and 2B (PP1, PP2A and PP2B, respectively) are homologous to approximately 45%, with the residues in the enzymatic centers strictly conserved. PP1, PP2A and PP2B are abundant in cells and they dephosphorylate serine and/or threonine residues in a variety of proteins serving as cellular phospho switches. The active enzymes work as invariant catalytic subunits PP1c, PP2Ac and PP2Bc, respectively, complexed with diverse regulatory subunits, dependent on the enzymes' specific location and biological function. The crystal structures of PP1c and PP2B (calcineurin) heterotetramer calcineurinA x calcineurinB x FKBP x FK506 have been determined. A comparison of the catalytic subunits of both enzymes indicates their significant structural homology and virtual identity within the catalytic centers, each including a set of conservative amino acids, two metal ions and a phosphate; thus confirming a hypothesis on their common enzymatic mechanisms. The elongated substrate cleft at the active centre is kinked by approximately 120 degrees at the active center in its middle and thus divided into a pre-phospho-Ser/Thr (ligand N-terminal) and a post-phospho-Ser/Thr (ligand C-terminal) section. In PP1c the N-terminal section is highly acidic while in PP2Bc is not. This feature is likely pertinent but not sufficient to the enzymes' selectivity, which is also controlled by regulatory subunits, diverse in various tissues. The metalloenzymes in general and PPP in particular are hard to deal with using theoretical simulations due to parameterization problems for the metal cations. In fact, there are only a few PP1c simulations reported, with the metal di-cations treated quite crudely. This is a preliminary work, in which we introduce and test against some experimental evidence a concept of pseudomolecules of proper geometry, composed of double metal (2Zn2+ or 2Mn2+) cation, and the OH- nuclephile incorporated into the PP1c catalytic site. Both models are associated with either the phosphate (a free enzyme) or the phosphorylated dodecapeptide RRRRPpTPAMLFR, an active fragment (residues 29-40) of a regulatory subunit DARPP-32 inhibitor (PP1c-inhibitor complex); four models total. We have parameterized both pseudomolecules within the AMBER force field. Subsequently, using molecular dynamic in water, we have found the free PP1c subunits to be less stable than the complexed ones and we have speculated on possible reasons for this feature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816008     DOI: 10.1016/s0097-8485(99)00079-0

Source DB:  PubMed          Journal:  Comput Chem        ISSN: 0097-8485


  6 in total

1.  AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine.

Authors:  Nadine Homeyer; Anselm H C Horn; Harald Lanig; Heinrich Sticht
Journal:  J Mol Model       Date:  2005-10-21       Impact factor: 1.810

2.  Zinc binds to and directly inhibits protein phosphatase 2A in vitro.

Authors:  Yan Xiong; Dan-Ju Luo; Xiu-Lian Wang; Mei Qiu; Yang Yang; Xiong Yan; Jian-Zhi Wang; Qi-Fa Ye; Rong Liu
Journal:  Neurosci Bull       Date:  2015-04-08       Impact factor: 5.203

3.  SDS22 selectively recognizes and traps metal-deficient inactive PP1.

Authors:  Meng S Choy; Thomas M Moon; Rini Ravindran; Johnny A Bray; Lucy C Robinson; Tara L Archuleta; Wuxian Shi; Wolfgang Peti; Kelly Tatchell; Rebecca Page
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 4.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Authors:  Jaya Sangodkar; Caroline C Farrington; Kimberly McClinch; Matthew D Galsky; David B Kastrinsky; Goutham Narla
Journal:  FEBS J       Date:  2015-11-14       Impact factor: 5.542

Review 5.  Regulation of Cardiac PKA Signaling by cAMP and Oxidants.

Authors:  Friederike Cuello; Friedrich W Herberg; Konstantina Stathopoulou; Philipp Henning; Simon Diering
Journal:  Antioxidants (Basel)       Date:  2021-04-24

6.  Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology.

Authors:  Persoulla Nicolaou; Evangelia G Kranias
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.